From Intricon expanding its manufacturing space to Arthrex signing a global distribution deal, here are seven medtech stories we missed this week but thought were still worth mentioning. 1. Intricon expands medical footprint Intricon announced in a March 13 press release that it has signed a 5-year lease that will secure 30,000 sq. ft of manufacturing […]
Tissue Regenix closes $30m CellRight acquisition
Tissue Regenix (LON:TRX) said today it closed its $30 million (£23 million) acquisition of CellRight Technologies and its line of spinal surgery and orthopedic products. Leeds, England-based Tissue Regenix said it expects that the acquisition will increase its US sales by more than double while expanding the company’s presence in the US healthcare market. Tissue Regenix’s technology is […]
Tissue Regenix slides after $30m buyout of CellRight Technologies
Tissue Regenix (LON:TRX) shares came under pressure today after the regenerative medicine company said it paid $30 million (£23 million) to acquire CellRight Technologies and its line of spine surgery and orthopedics products. Leeds, U.K.-based Tissue Regenix said it funded the deal with a $52 million (£40 million) flotation of 400 million shares. CellRight is based in San Antonio, […]
